2 not yet recruiting, 1 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Not yet recruiting 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow NTI164: new trials by email Literature Review of NTI164 trials Research Report on NTI164
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Fenix Innovation Group | 40 | 2027-07-01 | 2026-09-09 |
| NTI164 in Autism Spectrum Disorder NTI164, Placebo - Autism, Autism Spectrum Disorder | Phase 3 | Not yet recruiting | Fenix Innovation Group | 200 | 2026-09-30 | 2026-09-30 |
| Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder NTI164 - Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Fenix Innovation Group | 54 | 2022-11-30 | 2026-09-10 |
Autism Spectrum Disorder (2) · Marijuana Abuse (2) · Autistic Disorder (1) · Rett Syndrome (1)
Australia (3)